Self-Monitoring Blood Glucose (SMBG) Devices Global Market Report 2022: Rising Prevalence of Diabetes to Propel Sector Growth - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Self-Monitoring Blood Glucose (SMBG) Devices Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

The global self-monitoring blood glucose (SMBG) devices market is expected to grow from $11.99 billion in 2021 to $13.18 billion in 2022 at a compound annual growth rate (CAGR) of 9.9%. The self-monitoring blood glucose (SMBG) devices market is expected to grow to $18.10 billion in 2026 at a CAGR of 8.3%.

North America was the largest region in the self-monitoring blood glucose (SMBG) devices market in 2021. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this self-monitoring blood glucose (SMBG) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The rising prevalence of diabetes is expected to propel the growth of the self-monitoring blood glucose device market going forward. Self-monitoring of blood glucose is a method in which person with diabetes use a glycemic reading gadget to measure their blood sugar (glucose meter) where they can change or monitor the effectiveness of their treatment (diet, exercise, insulin, antidiabetics) or see their physician based on the results of the test.

For instance, according to the report published by International Diabetes Federation in 2021, there were 463 million individuals living with diabetes around the world in 2019, and increased to 537 million in 2021. Also, by the year 2030, the overall number of diabetics is expected to reach 643 million, and by 2045, it will reach 783 million. Therefore, the rising prevalence of diabetes is driving the growth of the self-monitoring blood glucose devices market.

Technological advancement is a key trend gaining popularity in the self-monitoring blood glucose devices market. Major companies operating in the self-monitoring blood glucose devices market are focused on developing technologically advanced products to strengthen their position in the market.

For instance, in September 2021, Know Labs Inc, a US-based company that manufactures glucose monitoring devices, launched a new portable medical-grade glucose monitoring device named KnowU that utilizes Bio-RFID technology. This device is a non-invasive glucose monitoring machine that has a base that powers the device and displays readings, and a battery-powered monitor with Bio-RFID sensors that can be carried by the users to check sugar levels on the go. The KnowU is an affordable and convenient replacement for other expensive and painful blood glucose monitoring devices.

Scope

Markets Covered:

1) By Product: Self-Monitoring Blood Glucose Meters; Continuous Glucose Monitors; Testing Strips; Lancets

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Sales; Diabetes Clinics & Centers

3) By Application: Type 1 Diabetes; Type 2 Diabetes; Gestational Diabetes

Key Topics Covered:

1. Executive Summary

2. Self-Monitoring Blood Glucose (SMBG) Devices Market Characteristics

3. Self-Monitoring Blood Glucose (SMBG) Devices Market Trends And Strategies

4. Impact Of COVID-19 On Self-Monitoring Blood Glucose (SMBG) Devices

5. Self-Monitoring Blood Glucose (SMBG) Devices Market Size And Growth

6. Self-Monitoring Blood Glucose (SMBG) Devices Market Segmentation

7. Self-Monitoring Blood Glucose (SMBG) Devices Market Regional And Country Analysis

8. Asia-Pacific Self-Monitoring Blood Glucose (SMBG) Devices Market

9. China Self-Monitoring Blood Glucose (SMBG) Devices Market

10. India Self-Monitoring Blood Glucose (SMBG) Devices Market

11. Japan Self-Monitoring Blood Glucose (SMBG) Devices Market

12. Australia Self-Monitoring Blood Glucose (SMBG) Devices Market

13. Indonesia Self-Monitoring Blood Glucose (SMBG) Devices Market

14. South Korea Self-Monitoring Blood Glucose (SMBG) Devices Market

15. Western Europe Self-Monitoring Blood Glucose (SMBG) Devices Market

16. UK Self-Monitoring Blood Glucose (SMBG) Devices Market

17. Germany Self-Monitoring Blood Glucose (SMBG) Devices Market

18. France Self-Monitoring Blood Glucose (SMBG) Devices Market

19. Eastern Europe Self-Monitoring Blood Glucose (SMBG) Devices Market

20. Russia Self-Monitoring Blood Glucose (SMBG) Devices Market

21. North America Self-Monitoring Blood Glucose (SMBG) Devices Market

22. USA Self-Monitoring Blood Glucose (SMBG) Devices Market

23. South America Self-Monitoring Blood Glucose (SMBG) Devices Market

24. Brazil Self-Monitoring Blood Glucose (SMBG) Devices Market

25. Middle East Self-Monitoring Blood Glucose (SMBG) Devices Market

26. Africa Self-Monitoring Blood Glucose (SMBG) Devices Market

27. Self-Monitoring Blood Glucose (SMBG) Devices Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Self-Monitoring Blood Glucose (SMBG) Devices Market

29. Self-Monitoring Blood Glucose (SMBG) Devices Market Future Outlook and Potential Analysis

30. Appendix

Companies Mentioned

• Abbott Laboratories
• Bionime Corporation
• B. Braun Melsungen AG
• F. Hoffmann-La Roche Ltd.
• LifeScan Inc
• PHC Holdings Corporation
• Home Diagnostics Inc.
• Terumo Pharmaceutical Solutions
• ARKRAY Inc.
• Ypsomed Holding AG
• Dexcom Inc.
• Medtronic Plc
• Novo Nordisk
• Glysens Incorporated
• Senseonics Holdings

For more information about this report visit https://www.researchandmarkets.com/r/gzw3pi

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900